| Date | Company | Event | Description | Result |
|---|---|---|---|---|
| Akebia Therapeutics | Phase 2 | Vadadustat, Anemia related to chronic kidney disease | Success | |
| Tetraphase Pharmaceuticals | Phase 3 | Eravacycline, Complicated urinary tract infections | Failure | |
| Flexion Therapeutics | PHASE 2B | FX006, osteoarthritis | Failure | |
| Trevena | Phase 2b | TRV-130, Painkiller | Success |